A drug challenge test in Parkinson’s disease, such as the levodopa challenge test (LCT), is
an easy and generally safe procedure, which has been used by clinicians for various …

Objective X‐linked dystonia parkinsonism (XDP) is a neurodegenerative movement disorder
caused by a single mutation: SINE‐VNTR‐Alu (SVA) retrotransposon insertion in TAF1. …

X-linked dystonia-parkinsonism is a neurodegenerative disorder caused by a founder
retrotransposon insertion, in which a polymorphic hexanucleotide repeat accounts for ~50% of …

Glutamatergic, noradrenergic, serotonergic, and cholinergic systems play a critical role in
the basal ganglia circuitry. Targeting these non-dopaminergic receptors remains a focus of …

Corticobasal degeneration (CBD) is a rare neurodegenerative disease characterized by the
predominance of pathological 4 repeat tau deposition in various cell types and anatomical …

MDSGene is an online database on movement disorders that collates genetic and clinical
knowledge using a standardized published literature abstraction strategy. This review is …

While many genetic causes of movement disorders have been identified, modifiers of
disease expression are largely unknown. X-linked dystonia-parkinsonism (XDP) is a …

The genetic combined dystonias are a clinically and genetically heterogeneous group of
neurologic disorders defined by the overlap of dystonia and other movement disorders such as …

Background Hereditary spastic paraplegia (HSP) is a rare genetic disorder associated with
mutations in > 80 loci designated SPG (SPastic parapleGia). The phenotypic spectrum of …

Background: X-linked dystonia-parkinsonism (XDP) is an adult-onset neurodegenerative
disorder characterized by progressive dystonia and parkinsonism. It is caused by a SINE-VNTR…